Skip to main content

Conduct post-market surveillance of therapeutic goods

ARTG-included goods must be monitored post-market for safety + performance.

criticalcurrentongoingCriminal liability
Who must comply
ARTG sponsors + manufacturers (medicines + devices + biologicals).
What triggers it
Inclusion of goods in the ARTG.
When due
Continuous; adverse-event reports per timeframes; periodic safety updates.
Evidence required
PMS plan; adverse-event register; safety updates; recall procedure.
Max penalty
Civil and criminal penalties under the Therapeutic Goods Act 1989 (for example, up to 5,000 penalty units ($1.82M) for an individual and 50,000 penalty units ($18.2M) for a body corporate for supplying unregistered medical devices); ARTG cancellation

Who must comply with this? The applicability test by industry, business structure and size.

Summary

Conditions of ARTG inclusion and registration, the Therapeutic Goods Regulations 1990 and the Therapeutic Goods (Medical Devices) Regulations 2002 require sponsors to conduct post-market surveillance — adverse-event reporting, safety updates, recall when warranted. Medical-device manufacturers operate quality management systems aligned to ISO 13485 with TGA conformity assessment.

Enforced by

Source legislation

Industries

Topics

medicinespmstga

Related

Frequently asked questions

Who must comply with post-market surveillance of therapeutic goods?
ARTG sponsors + manufacturers (medicines + devices + biologicals).
What triggers post-market surveillance of therapeutic goods?
Inclusion of goods in the ARTG.
When is post-market surveillance of therapeutic goods due?
Continuous; adverse-event reports per timeframes; periodic safety updates.
What is the maximum penalty for post-market surveillance of therapeutic goods?
Civil and criminal penalties under the Therapeutic Goods Act 1989 (for example, up to 5,000 penalty units ($1.82M) for an individual and 50,000 penalty units ($18.2M) for a body corporate for supplying unregistered medical devices); ARTG cancellation
What evidence is required for post-market surveillance of therapeutic goods?
PMS plan; adverse-event register; safety updates; recall procedure.

Source: https://www.tga.gov.au/safety. Rules Mate is not a law firm. Always verify against the live regulator source before acting.